▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1458 by analyst upside · 2026-09-16
ABVX
ABIVAX Société Anonyme
Healthcare · Market Cap $9B · P/E 0x
ANALYST PRICE TARGET
+54.7%
implied upside to consensus target
Current Price $106.66
Consensus Target $165.0
Bull Target $187.0
Bear Target $142.0
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
4
Buy
8
Hold
0
Sell
0
52-Week Low $69.81
52-Week High $148.83
YTD Return -20.3%
FUNDAMENTALS
Market Cap $9B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-5.03
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $5M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $69.81
52-Week High $148.83
Current Price $106.66
Bear Target $142.0
Bull Target $187.0
● Now $106.66 ● Target $165.0
TRADING DATA
Avg Volume 1.4M
YTD Return -20.3%
Analyst Count 12
Consensus Buy
Upside to Target +54.7%
Last Updated 2026-09-16

ANALYST SUMMARY

ABIVAX Société Anonyme (ABVX) is currently trading at $106.66 with a Wall Street consensus price target of $165.0, implying potential upside of 54.7% over the next 12 months. 12 analysts currently cover ABVX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $187.0, while the most cautious has a target of $142.0.

ABVX operates in the Healthcare sector with a market capitalisation of $9B. The stock is down 20.3% year-to-date and is currently trading near the lower end of its 52-week range of $69.81 – $148.83.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

GMED +38.2%
Globus Medical, Inc.
$10B · P/E 19.4x · Buy
TGTX +31.4%
TG Therapeutics, Inc.
$8B · P/E 19.7x · Buy
COO +24.3%
The Cooper Companies, Inc.
$10B · P/E 18.6x · Hold
UHS +9.7%
Universal Health Services, Inc.
$10B · P/E 7.1x · Hold
ATR +36.5%
AptarGroup, Inc.
$8B · P/E 22.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ABVX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Goldman Sachs ● Initiated
Buy 2026-09-10 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-07-09 14% win rate (7 calls)
Truist Securities - Reiterated
Buy → Buy 2026-07-02 Building track record
Citizens reit
Market Outperform → Market Outperform 2026-07-01 Building track record
Jefferies ↑ Upgrade
Hold → Buy 2026-06-30 50% win rate (6 calls)
Leerink Partners - Reiterated
Outperform → Outperform 2026-06-30 29% win rate (7 calls)
Wedbush - Reiterated
Neutral → Neutral 2026-06-30 Building track record
BTIG - Reiterated
Buy → Buy 2026-06-30 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
69
out of 100
Coverage depth
20/30
Consensus clarity
22/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →